Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
928.0000
-2.00
(
-0.22
%)
NSE
Jun 02, 2025
15:31 PM
29.93% Fall from 52W High
Volume:
817.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
29 Apr 2023
US FDA Approval
928.00
-0.22%
Zydus Lifesciences Ltd. target price 597
Buy:
Zydus Lifesciences Ltd.
by
BP Wealth
Target: 597
BP Wealth
Zydus Lifesciences Ltd. is trading
below its 150 day SMA
of 934.9
More from Zydus Lifesciences Ltd.
Recommended
IPOs This Week: Prostarm, Scoda Tubes Plus Six Listings, and A New Issue
|
02 Jun 2025, 04:29PM
Market closes flat, Inox Wind's Q4 revenue rises 132.8% YoY to Rs 1,310.7 crore
Trendlyne Marketwatch |
02 Jun 2025, 04:02PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020